LECT2 and metabolic dysfunction-associated steatotic liver disease: The participants with NAFLD had significantly higher plasma LECT2 levels compared to their non-NAFLD counterparts (34.4 [29.3–41.1] vs. 29.0 [24.7–36.7] ng/mL, p < 0.001).